Cenduit, LLC Company Profile
Cenduit is a privately owned joint venture of Quintiles and Fisher Clinical Services, part of Thermo Fisher Scientific. Cenduit has successfully deployed IRT solutions in over 650 clinical studies. Cenduitâs IRT solution is currently being used in Phase I through Phase IV clinical trials by over 16,000 sites in 78 countries, to enroll more than 220,000 subjects for over 30 indications. There are currently 46 languages utilized in the Cenduit IRT platform, supporting all languages in the ISO country list. Cenduit is dedicated to Quality, Partnership, Efficiency, and Exemplary Customer Service. Cenduit has over 200 domain specialists consisting of project management, technical, validation, programming, and quality control/assurance global staff located in Research Triangle Park, North Carolina USA, Allentown, Pennsylvania USA, Horsham, London UK, Basel, Switzerland, and Bangalore, India.
News Articles
Cenduit to expand its offices in US, Switzerland
Patient randomization and clinical supplies management services provider Cenduit is expanding its headquarters in Durham, North Carolina,US, and its office in Basel, Switzerland.
Cenduit Chosen as a Finalist in Technology Competition
Cenduit LLC, a provider of services to the pharmaceutical, biopharmaceutical and medical device industries, has been chosen as a finalist for the North Carolina Technology...
Cenduit Announces Expansion in Europe and the USA and Appoints Global Head of Technology
Cenduit LLC, a leading global provider of patient randomization and clinical supplies management services, has announced the expansion of its Durham, N.C., headquarters and...
Cenduit Introduces New Clinical Trial Supply Simulation and Forecasting Service
Cenduit LLC has introduced a new study simulation and forecasting service that will enable clinical trial sites to better plan and control supplies for their patients. When...
Cenduit Appoints John Cline as Vice President of Client Services
Cenduit LLC, a provider of interactive response technology (IRT) for clinical trials around the world, continues to offer an unprecedented level of support for its clients...
Cenduit expands in Europe and U.S.
Cenduit, a global provider of patient randomization and clinical supplies management services, has announced the expansion of its Durham, N.C., headquarters and its office in Basel, Switzerland. The e...
Stefan Dürr, Cenduit LLC associate director of project management and an expert in interactive response technology (IRT), will discuss how to avoid the risks of patient or...
Cenduit launches new study supply simulation and forecasting service
Cenduit, a provider of interactive response technology (IRT)-driven services for clinical trials, has introduced a new study simulation and forecasting service that will enable clinical trial sites to...
Drugs and Medications
None
PubMed Articles
None
Clinical Trials
None
Companies
Cenduit provides interactive response technology (IRT) - driven services for clinical trials around the world. Cenduitâs IRT solutions deliver optimized clinical suppl...
Cenduit is a privately owned joint venture of Quintiles and Fisher Clinical Services, part of Thermo Fisher Scientific. Cenduit has successfully deployed IRT solutions in over 650...
More Information about "Cenduit, LLC" on BioPortfolio
We have published hundreds of Cenduit, LLC news stories on BioPortfolio along with dozens of Cenduit, LLC Clinical Trials and PubMed Articles about Cenduit, LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Cenduit, LLC Companies in our database. You can also find out about relevant Cenduit, LLC Drugs and Medications on this site too.
